P&K Skin Research Center Co. Ltd Cash Flow-to-Debt Ratio
P&K Skin Research Center Co. Ltd cash flow-to-debt ratio. P&K Skin Research Center Co. Ltd (347740) has a Cash Flow-to-Debt Ratio of 0.38x as of September 2025, meaning its operating cash flow of ₩1.70 Billion could theoretically repay 0% of its total liabilities (₩4.49 Billion) in one year. Check cash flow quality index of P&K Skin Research Center Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of P&K Skin Research Center Co. Ltd (2018–2024)
Cash flow-to-debt ratio of P&K Skin Research Center Co. Ltd from 2018 to 2024. Historical debt coverage capacity for P&K Skin Research Center Co. Ltd across 7 annual periods. Check how aggressively does P&K Skin Research Center Co. Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
P&K Skin Research Center Co. Ltd Cash Flow-to-Debt Ratio by Year (2018–2024)
P&K Skin Research Center Co. Ltd cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for P&K Skin Research Center Co. Ltd. For the full cash flow conversion analysis, see 347740 cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.77x | ₩9.03 Billion | ₩5.10 Billion | ▲ +1.0% |
| 2023 | 1.75x | ₩5.55 Billion | ₩3.17 Billion | ▼ -12.9% |
| 2022 | 2.01x | ₩7.51 Billion | ₩3.73 Billion | ▲ +5.2% |
| 2021 | 1.91x | ₩7.70 Billion | ₩4.03 Billion | ▼ -5.9% |
| 2020 | 2.03x | ₩8.67 Billion | ₩4.27 Billion | ▲ +8.6% |
| 2019 | 1.87x | ₩6.49 Billion | ₩3.47 Billion | ▼ -26.2% |
| 2018 | 2.53x | ₩4.26 Billion | ₩1.68 Billion | — |